P25 Prof. Dr. Boor/Prof. Dr. Floege
Zell-spezifische Rolle von PDGF in Nierenfibrose

Wir wollen die Rolle von PDGF-BB, dem Liganden beider PDGF Rezeptorketten α und β, in progressiven Nierenkrankheiten durch genetische Deletion von PDGF-B in einer zellspezifischen Weise analysieren. Zusätzlich soll die Rolle des PDGFR Signalweges in perivaskulären Gli1+ Vorläuferzellen der Nieren- aber auch Lebermyofibroblasten mit Hilfe von transgenen Mäusen mit induzierbaren, konstitutiv aktiven PDGFR-Mutanten spezifisch in Gli1+ Zellen geklärt werden. Schließlich wollen wir die Komponenten des PDGF-Systems als potentielle Biomarker oder molekulare Bildgebungsverfahren zur nicht-invasiven Diagnostik der Nierenfibrose analysieren. [...]

Publikationen

• Kuppe C. , Ibrahim M. M., Kranz J., Zhang X., Ziegler S., Perales-Patón J., Jansen J., Reimer K. C., Smith J. R., Dobie R., Wilson-Kanamori J. R., Halder M., Xu Y., Kabgani N., Kaesler N., Klaus M., Gernhold L., Puelles V. G., Huber T. B., Boor P., Menzel S., Hoogenboezem R. M., Bindels E. M. J., Steffens J., Floege J., Schneider R. K., Saez-Rodriguez J., Henderson N. C., Kramann R. (2020): Decoding myofibroblast origins in human kidney fibrosis. nature, 589, 281–286,
• Klinkhammer B. M. , Djudjaj S., Kunter U., Palsson R., Edvardsson V. O., Wiech T., Thorsteinsdottir M., Hardarson S., Foresto-Neto O., Mulay S. R., Moeller M. J., Jahnen-Dechent W., Floege J., Anders H.J., Boor P. (2020): Cellular and Molecular Mechanisms of Kidney Injury in 2,8-Dihydroxyadenine Nephropathy. Journal of American Society of Nephrology, 31(4), 799-816, [8.491]
• Baues M. , Klinkhammer B. M., Ehling J., Gremse F., van Zandvoort M. A. M. J., Reutelingsperger C. P. M., Daniel C., Amann K., Bábíčková J., Kiessling F., Floege J., Lammers T., Boor P. (2020): A collagen-binding protein enables molecular imaging of kidney fibrosis in vivo. Kidney International, 97(3), 609-614, [8.306]
• Echle A. , Grabsch H. I., Quirke P., van den Brandt P. A., West N. P., Hutchins G. G. A., Heij L. R., Tan X., Richman S. D., Krause J., Alwers E., Jenniskens J., Offermans K., Gray R., Brenner H., Chang-Claude J., Trautwein C., Pearson A. T., Boor P., Luedde T., Gaisa N. T., Hoffmeister M., Kather J. N. (2020): Clinical-Grade Detection of Microsatellite Instability in Colorectal Tumors by Deep Learning. Gastroenterology, 159, 1406-1416,
• Hermert D. , Martin I. V., Reiss L. K., Liu X., Breitkopf D. M., Reimer K. C., Alidousty C., Rauen T., Floege J., Ostendorf T., Weiskirchen R., Raffetseder U. (2020): The nucleic acid binding protein YB-1-controlled expression of CXCL-1 modulates kidney damage in liver fibrosis. Kidney International, 97(4), 741-752, [8.306]
• van Roeyen C. R. C. , Martin I. V., Drescher A., Schuett K. A., Hermert D., Raffetseder U., Otten S., Buhl E. M., Braun G., Kuppe C., Liehn E., Boor P., Weiskirchen R., Eriksson U., Gross O., Eitner F., Floege J., Ostendorf T. (2019): Identification of platelet-derived growth factor C as a mediator of both renal fibrosis and hypertension. Kidney Int, 95, 1103-1119, [8.000]
• Tajti F. , Kuppe C., Antoranz a., Ibrahim M. M., Kim H., Ceccarelli F., Holland C. H., Olauson H., Flege J., Alexopoulos L. G., Kramann R., Saez-Rodriguez J. (2019): A functional landscape of chronic kidney disease entities from public transcriptomic data. Kidney International Reports, [2.260]
• Sun Q. , Baues M., Klinkhammer B. M., Ehling J., Djudjaj S., Drude N. I., Daniel C., Amann K., Kramann R., Kim H., Saez-Rodriguez J., Weiskirchen R., Onthank D. C., Botnar R. M., Kiessling F., Floege J., Lammers T., Boor P. (2019): Elastin imaging enables non-invasive staging and treatment monitoring of kidney fibrosis. Sci Transl Med, 11, 486, [17.161]
• Puelles V. G. , Fleck D., Ortz L., Papadouri S., Strieder T., Boehner A., van der Wolde J. W., Vogt M., Saritas T., Kuppe C., Fuss A., Menzel S., Klinkhammer B. M., Müller-Newen G., Heymann F., Decker L., Braun F., Kretz O., Huber T. B., Susaki E. A., Ueda H. R., Boor P., Floege J., Kramann R., Kurts C., Bertram J. F., Spehr M., Nikolic-Paterson D. J., Moeller M. J. (2019): 3D analysis of rapidly progressive glomerulonephritis using optical tissue clearing. Kidney Int, 96, 505-516, [8.306]
• Poluzzi C. , Nastase M. V., Zeng-Brouwers J., Roedig H., Hsieh L. T. H., Michaelis J. B., Abderrahman N. B., Buhl E. M., Rezende F., Manavski Y., Bleich A., Boor P., Brandes R. P., Pfeilschifter J., Stelzer E. H. K., Münch C., Dikic I., Brandts C., Iozzo R. V., Wygrecka M. Schaefer L. (2019): Biglycan evokes autophagy in macrophages via a novel CD44/Toll-like receptor 4 signaling axis: Impact on renal ischemia/reperfusion injury. Kidney Int, 95, 540-562, [8.429]
• Mulay S. R. , Honarpisheh M. M., Foresto-Neto O., Shi C., Desai J., Zhao Z. B., Marschner J. A., Popper B., Buhl E. M., Boor P., Linkermann A., Liapis H., Bilyy R., Herrmann M., Romagnani P., Belevich I., Jokitalo E., Becker J. U., Anders H. J. (2019): Mitochondria Permeability Transition versus Necroptosis in Oxalate-Induced AKI. Am Soc Nephrol., 30, 1857-1869, [8.547]
• Kuppe C. , Leuchtle K., Wagner A., Kabgani N., Saritas T., Puelles V. G., Smeets B., Hakroush S., van der Vlag J., Buhl E. M., Boor P., Schiffer M., Gröne H. J., Fogo A., Floege J., Moeller M. J. (2019): Novel parietal epithelial cell subpopulations in FSGS and the origin of the glomerular tip lesion. Kidney Int, 96, 80-93, [8.306]
• Klein S. , Frohn F., Magdaleno F., Reker-Smit C., Schierwagen R., Schierwagen I., Uschner F. E., Fürst D. O., Djudjaj S., Boor P., Poelstra K., Beljaars L., Trebicka J. (2019): Rho-kinase inhibitor coupled to peptide-modified albumin carrier reduces fibrogenesis and portal pressure in cirrhotic rats with increased renal perfusion. Sci Rep, 9, 2256, [4.011]
• Kather J. N. , Pearson A. T., Halama N., Jäger D., Krause J., Loosen S. H., Marx A., Boor P., Tacke F., Neumann U. P., Grabsch H. I., Yoshikawa T., Brenner H. B., Chang-Claude J., Hoffmeister M., Trautwein C., Luedde T. (2019): Deep learning can predict microsatellite instability directly from histology in gastrointestinal cancer. Nat Med, 25, 1054-1056, [30.641]
• Hermert D. , Martin I.V., Reiss L.K., Breitkopf D.M., Rauen T., Floege J., Ostendorf T., Weiskirchen R., Raffetseder U. (2019): YB-1-controlled CXCL-1 expression decides on kidney damage in liver fibrosis. Kidney Int, [8.395]
• Gadermayr M. , Gupta L., Appel V., Boor P., Klinkhammer B. M., Merhof D. (2019): Generative Adversarial Networks for Facilitating Stain-Independent Supervised & Unsupervised Segmentation: A Study on Kidney Histology. IEEE Trans Med Imaging (TMI), 38, 2293-2302, [7.816]
• Breitkopf D. M. , Jankowski V., Ohl K., Hermann J., Hermert D., Tenbrock K., Liu X., Martin I. V., Wang J., Groll F., Gröne E., Floege J., Ostendorf T., Rauen T., Raffetseder U. (2019): The YB-1:Notch-3 axis modulates immune cell responses and organ damage in systemic lupus erythematosus. Kidney Int, in press, [8.306]
• Stoppe C. , Averdunk L., Goetzenich A., Soppert J., Marlier A., Kraemer S., Vieten J., Coburn M., Stevanovic A., Kim B.-S., Marx G., Rex S., Ochi A., Leng L., Moeckel G., Linkermann A., El Bounkari O., Zarbock A., Bernhagen J., Djudjaj S., Bucala R., Boor P. (2018): The protective role of macrophage migration inhibitory factor in acute kidney injury after cardiac surgery. Sci Transl Med, 10, 4886, [23.401]
• Müller S. , Djudjaj S., Lange J., Iacovescu M., Goppelt-Struebe M., Boor P. (2018): HIF stabilization inhibits renal epithelial cell migration and is associated with cytoskeletal alterations. Sci Rep, 8, 9497, [4.011]
• Moellmann J. , Klinkhammer B. M., Onstein J., Stöhr R., Jankowski V., Jankowski J., Lebherz C., Tacke F., Marx N., Boor P., Lehrke M. (2018): Glucagon-like peptide-1 and its cleavage products are renoprotective in murine diabetic nephropathy. Diabetes, 67(11), 2410-2419, [7.199]
• Martin I. V. , Bohner A., Boor P., Shagdarsuren E., Raffetseder U., Lammert F., Floege J., Ostendorf T., Weber S. N. (2018): Complement C5a receptors C5L2 and C5aR in renal fibrosis. Am J Physiol Renal Physiol, 314, F35-F46, [3.611]
• Gross A. , Pack L. A. P., Schacht G. M., Kant S., Ungewiss S., Meir M., Schlegel N., Preisinger C., Boor P., Güldiken N., Krusche C. A., Sellge G., Trautwein C., Waschke J., Heuser A., Leube R. E., Strnad P. (2018): Desmoglein 2, but not desmocollin 2, protects intestinal epithelia from injury. Mucosal Immunol, 11, 1630-1639, [7.352]
• Gibbert L. , Hermert D., Wang J., Breitkopf D. M., Alidousty C., Neusser M., Cohen C. D., Gröne E., Macheleidt I., Rauen T., Braun G. S., Floege J., Ostendorf T., Raffetseder U. (2018): YB-1 increases glomerular, but decreases interstitial fibrosis in CNI-induced nephropathy. Clin Immunol, 194, 67-74, [3.557]
• Gadermayr M. , Dombrowski A.-K., Klinkhammer B. M., Boor P., Merhof D. (2018): CNN Cascades for Segmenting Sparse Objects in Gigapixel Whole Slide Images. Comput Med Imaging Graph, 71, 40-48, [3.298]
• Buchtler S. , Grill A., Hofmarksrichter S., Stöckert P., Schiechl-Brachner G., Rodriguez Gomez M., Neumayer S., Schmidbauer K., Talke Y., Klinkhammer B. M., Boor P., Medvinsky A., Renner K., Castrop H., Mack M. (2018): Cellular Origin and Functional Relevance of Collagen I Production in the Kidney. J Am Soc Nephrol, 29(7), 1859-1873, [8.547]
• Martin, I.V. , Bohner, A., Boor, P., Shagdarsuren, E., Raffetseder, U., Lammert, F., Floege, J., Ostendorf, T., Weber, S.N. (2017): Complement C5a receptors C5L2 and C5aR in renal fibrosis. American Journal of Physiology, 314 (1), 35-46, [27.312]
• Djudjaj, S. , Martin, I.V., Buhl, E.M., Nothofer, N.J., Leng, L., Piecychna, M., Floege, J., Bernhagen, J., Bucala, R., Boor, P. (2017): Macrophage Migration Inhibitory Factor limits renal Inflammation and fibrosis by counteracting tubular cell cycle arrest. Journal of the American Society of Nephrology, 28 (12), [8.491]
• Heier E.C. , Meier A., Julich-Haertel H., Djudjaj S., Rau M., Tschernig T., Geier A., Boor P., Lammert F., Lukacs-Kornek V. (2017): CD103+ dendritic cells protect against steatosis progression towards steatohepatitis. Journal of Hepathology, 66(6), 1241-1250, [10.590]
• Bábíčková J. , Klinkhammer B.M., Buhl E.M., Djudjaj S., Hoss M., Heymann F., Tacke F., Floege J., Becker J.U., Boor P. (2017): Regardless of etiology, progressive renal disease causes ultrastructural and functional alterations of peritubular capillaries. Kidney International, 91(1), 70-85, [7.683]
• Klinkhammer B.M. , Goldschmeding R., Floege J., Boor P. (2017): Treatment of Renal Fibrosis – turning challenges into opportunities. Advances in Chronic Kidney Disease, 24(2),, 117–129, [2.703]
• Wang, J. , Djudjaj, S., Gibbert, L., Lennartz, V., Breitkopf, D., Rauen, T., Hermert, D., Martin, I.V., Boor, P., Braun, G.S., Floege, J., Ostendorf, T., Raffetseder, U. (2017): YB-1 mediates both, onset an resolution of inflammation. Journal of Cellular and Molecular Medicine, [5.090]
• Wang J. , Gibbert L., Djudjaj S., Alidousty C., Rauen T., Kunter U., Rembiak A., Enders D., Jankowski V., Braun G. S., Floege J., Ostendorf T., Raffetseder U. (2016): Therapeutic nuclear shuttling of YB-1 reduces renal damage and fibrosis. Kidney Int, 90, 1226-1237, [8.395]
• Wang J. , Gibbert L., Djudjaj S., Alidousty C., Rauen T., Kunter U., Rembiak A., Enders D., Jankowski V., Braun G. S., Floege J., Ostendorf T., Raffetseder U. (2016): Therapeutic nuclear shuttling of YB-1 reduces renal damage and fibrosis. Kidney Int, 90, 1226-1237, [8.395]
• Ludwig-Portugall I., , Bartok E., Dhana E., Evers B.D.G., Primiano M.J., Hall J.P., Franklin B.S., Knolle P.A., Hornung V., Hartmann G., Boor P, Latz E., Kurts C. (2016): An NLRP3-specific inflammasome inhibitor attenuates crystal-induced kidney fibrosis in mice. Kidney International, 90(3), 525–539, [7.683]
• von Stillfried S. , Apitzsch J.C., Ehling J., Penzkofer T., Mahnken A.H., Knüchel R., Floege J., Boor P. (2016): Contrast-enhanced CT imaging in patients with chronic kidney disease. Angiogenesis, 19(4), 525–535, [4.301]
• Guldiken N. , Ensari G.K., Lahiri P., Couchy G., Preisinger C., Liedtke C., Zimmermann H.W., Ziol M., Boor P., Zucman-Rossi J., Trautwein C., Strnad P. (2016): Keratin 23 is a general stress-inducible marker of mouse and human ductular reaction in liver disease. Journal of Hepatology, 65(3), 552–559, [10.590]
• Beyer M. , Abdullah Z, Chemnitz JM, Maisel D, Sander J, Lehmann C, Thabet Y, Shinde PV, Schmidleithner L, Köhne M, Trebicka J, Schierwagen R, Hofmann A, Popov A, Lang KS, Oxenius A, Buch T, Kurts C, Heikenwalder M, Fätkenheuer G, Lang PA, Hartmann P, Knolle PA, Schultze JL (2016): Tumor-necrosis factor impairs CD4(+) T cell-mediated immunological control in chronic viral infection.. Nat Immunol, May;17(5), 593-603. doi: 10.1038/ni.3399. Epub 2016 Mar 7. PubMed PMID: 26950238,
• Evers B.D.G. , Engel D.R., Böhner A.M.C., Tittel A.P., Krause T.A., Heuser C., Garbi N., Kastenmüller W., Mack M., Tiegs G., Panzer U., Boor P., Ludwig-Portugall I., Kurts C. (2016): CD103+ Kidney Dendritic Cells Protect against Crescentic GN by Maintaining IL-10–Producing Regulatory T Cells. Journal of the American Society of Nephrology, 27(11), 3368-3382, [8.491]
• Ehling, J. , Bábíčková, J., Gremse, F., Klinkhammer, B. M., Baetke, S. H., Knuechel, R., Kiessling, F., Floege, J., Lammers, T., Boor, P. (2016): Quantitative micro-CT imaging of micro-to-macrovascular dysfunction in progressive kidney diseases. Journal of the American Society of Nephrology], 27(2), 520–532, [8.491]
• Djudjaj, S. , Lue, H. J., Rong, S., Papasotiriou, M., Klinkhammer, B. M., Zok, S., Klaener, O., Braun, G. S., Lindenmeyer, M. T., Cohen, C. D., Bucala, R., Tittel, A. P., Kurts, C., Moeller, M. J., Floege, J., Boor, P. (2016): Macrophage migration inhibitory factor mediates proliferative glomerulonephritis via CD74. Journal of the American Society of Nephrology, 27 (6), 1650-1664, [8.491]
• Djudjaj S. , Papasotiriou M., Bülow R.D., Wagnerova A., Lindenmeyer M.T., Cohen C.D., Bucala R., Strnad P., Goumenos D.S., Floege J., Boor P. (2016): Keratins as Novel Markers of Renal Epithelial Cell Injury. Kidney International, 89 (4), 792-808, [7.683]
• Celec P. , Tóthová L., Šebeková L., Podracká L., Boor P. (2016): Salivary markers of kidney function - potentials and limitations. Clinica Chimica Acta, 453, 28-37, [2.799]
• Braun, G. S. , Nagayama, Y., Maruta, Y., Heymann, F., van Roeyen, C. R., Klinkhammer, B. M., Boor, P., Villa, L., Salant, D. J., Raffetseder, U., Rose-John, S., Ostendorf, T., Floege, J. (2016): Interleukin-6 trans-signaling drives murine crescentic glomerulonephritis.. Journal of the American Society of Nephrology, 27 (1), 132-142, [8.491]
• Boor P. (2016): Albuminuria — a marker of systemic microvascular function. Nature Reviews Nephrology, 12(8), 449-50, [9.463]
• Buhl, E. M. , Djudjaj, S., Babickova, J., Klinkhammer, B. M., Folestad, E., Borkham-Kamphorst, E., Weiskirchen, R., Hudkins, K., Alpers, C. E., Eriksson, U., Floege, J., Boor, P. (2016): Role of PDGF-D in healthy and fibrotic kidneys.. Kidney Int, 89, 848-861, [7.683]
• Kuppe, C. , Gröne, H. J., Ostendorf, T., van Kuppevelt, T. H., Boor, P., Floege, J., Smeets, B., Moeller, M. J. (2015): Common histological patterns in glomerular epithelial cells in secondary focal segmental glomerulosclerosis.. Kidney Intdoi, 10.1038, ki.2015.116, [7.683]
• Görtz, D. (2015): Anti-interleukin-6 therapy through application of a monogenic protein inhibitor via gene delivery. Sci Rep, [5.580]
• Toivola, D. M. , Boor, P., Alam, C., Strnad, P. (2015): Keratins in health and disease.. Current Opinion in Cell Biology, 32, 73-81, [8.851]
• Schierwagen, R. , Maybüchen, L., Zimmer, S., Hittatiya, K., Bäck, C., Klein, S., Uschner, F. E., Reul, W., Boor, P., Nickenig, G., Strassburg, C. P., Trautwein, C., Plat, J., Lütjohann, D., Sauerbruch, J. (2015): Seven weeks of Western diet in apolipoprotein-E-deficient mice induce metabolic syndrome and non-alcoholic steatohepatitis with liver fibrosis. Sci Rep, Aug 11;5, 12931, [5.580]
• Papasotiriou, M. , Genovese, F., Klinkhammer, B. M., Kunter, U., Nielsen, S. H., Karsdal, M. A., Floege, J., Boor, P. (2015): Serum and urine markers of collagen degradation reflect renal fibrosis in experimental kidney diseases.. Nephrol Dial Transplant, 30, 1112-1121, [4.085]
• Kalenski, J. , ., Mancina, E., Paschenda, P., Beckers, C., Bleilevens, C., Tóthová, L'., Boor, P., Doorschodt, B. M., Tolba, R.H. (2015): Improved Preservation of Warm Ischemia Damaged Porcine Kidneys after Cold Storage in Ecosol, a Novel Preservation Solution.. Annals of Transplantation, 20, 233-242, [1.032]
• Genovese, F. , Boor, Ü., Üaüasotiriou, M., Leeming, D. J., Karsdal, M. A., Floege, J. (2015): Turnover of type III collagen reflects disease severity and is associated with progression and microinflammation in patients with IgA nephropathy.. Nephrol Dial Transplant, pii, gfv, 301, [3.580]
• Engel, D. R. , Krause, T., Snelgrove, S., Thiebes, S., Boor, P., Kitching, R., Kurts, C. (2015): (2015): CX3CR1 reduces kidney fibrosis by inhibiting local proliferation of profibrotic macrophages.. J Immunol, 194, 1628-1638, [4.920]
• Djudjaj, S , Lue, H. J., Rong, S., Papasotiriou, M., Klinkhammer, B. M., Zok, S., Klaener, O., Braun, G. S., Lindenmeyer, M. T., Cohen, C. D., Bucala, R., Tittel, A. P., Kurts, C., Moeller, M. J., Floege, J., Boor, P. (2015): Macrophage migration inhibitory factor mediates proliferative glomerulonephritis via CD74.. J Am Soc Nephrol, , in press, [9.340]
• Boor, P. , Bábíčková, J., Steegh, F., Hautvast, P., Martin, I. V., Djudjaj, S., Nakagawa, T., Ehling, J., Gremse, F., Bücher, E., Eriksson, U., van Roeyen, C. R. C., Eitner, F., Lammers, T., Floege, T. (2015): Role of PDGF-CC in capillary rarefaction in renal fibrosis.. Am J Pathol, 185, 2132-2142, [4.590]
• Boor, P. , Papasptiriou, M. E. (2015): If you lose your nerves, at least you will not get kidney fibrosis!. Kidney Int, 87(2), 275-277, [8.560]
• Boor, P , Perkuhn, M., Weibrecht, M., Zok, S., Martin, I. V., Gieseke, J., Schoth, F., Ostendorf, T., Kuhl, C., Floege, J. (2015): Diffusion-weighted MR imaging does not reflect kidney fibrosis in rat model of fibrosis.. JMRI, 1002/jmri, 24853, [2.510]
• Nagayama, Y. (2014): Gp130-dependent signaling in the podocyte.. American Journal of Physiology Renal Physiology, 307 (3), F346-F355, [3.390]
• Kim, S. , Becker, J., Bechheim, M., Kaiser, V., Noursadeghi, M., Fricker, N., Beier, E., Klaschik, S., Boor, P., Hess, T., Hofmann, A., Holdenrieder, S., Wendland, J., Fröhlich, H., Hartmann, G., Nöthen, M., Müller-Myhsok, B., Pütz, B., Hornung, V., Schumacher, J. (2014): Characterizing the genetic basis of innate immune response in TLR4-activated human monocytes. Nature Communications, 5, 5236, [11.329]
• Alidousty, C. , Rauen, T., Hanssen, L., Wang, Q., Alampour-Rajabi, S., Mertens, P.R., Bernhagen, J., Floege, J., Ostendorf, T., Raffetseder, U. (2014): Calcineurin-mediated YB-1 dephosphorylation regulates CCL5 expression during monocyte differentiation.. Journal of Biological Chemistry, [4.258]
• Berger, K. , Bangen, J. M., Hammerich, L., Liedtke, C., Floege, J., Smeets, B., Moeller, M. J. (2014): Origin of regenerating tubular cells after acute kidney injury.. Proc Natl Acad Sci U S A, 111(4), 1533-1538, [9.423]
• Wögenstein, K. L. , Szabo, S., Lunova, M., Wiche, G., Haybaeck, J., Strnad, P., Boor, P., Wagner, M., Fuchs, P. (2014): Epiplakin-deficiecy aggravates caerulein-induced murine pancreatitis by impaired acinar keratin filament reorganization. PLoS One, 18 (9), e108323, [3.057]
• Smeets, B. , Stucker, F., Wetzels, J., Brocherigou, I., Ronco, P., Gröne, H. J., D'Agati, V., Fogo, A., van Kuppevelt, T. H., Fischer, H. P., Boor, P., Floege, J., Ostendorf, T., Moeller, M. J. (2014): Detection of activated parietal epithelial cells on the glomerular tuft distinguishes early focal segmental glomerulosclerosis from minimal change disease. The American Journal of Pathology, 184, 3240-3248, [4.206]
• Schulte, K. , Berger, K., Boor, P., Jirak, P., Gelman, I. H., Arkull, K. P., Neal, C. R., Kriz, W., Floege, J., Smeets, B., Moeller, M. J. (2014): Origin of Parietal Podocytes in Atubular Glomeruli Mapped by Lineage Tracing. Journal of the American Society of Nephrology, 25(1), 129-141, [8.491]
• Ostendorf, T. , Boor, P., van Roeyen, C. R. C., Floege, J. (2014): Platelet Derived Growth Factors (PDGFs) in Glomerular and Tubulointerstitial Fibrosis.. Kidney International Supplements, 4, 65-69, [7.026]
• Genovese, F. , Manresa, A. A., Leeming, D. J., Karsdal, M. A., Boor, P. (2014): The extracellular matrix in the kidney: a source of novel non-invasive biomarkers of kidney fibrosis?. Fibrogenesis &Tissue Repair, 7(1), 4, [2.329]
• Boor, P. , Ostendorf, T., Floege, J. (2014): PDGF and the progression of renal disease. Nephrology Dialysis Transplantation, 29, 45-54, [4.085]
• Berger, K. , Schulte, K., Boor, P., Kuppe, C., van Kuppevelt, T. H., Floege, J., Smeets, B., Moeller, M. J. (2014): The Regenerative Potential of Parietal Epithelial Cells in Adult Mice.. J Am Soc Nephrol., 25(4), 693-705, [8.491]
• Klinkhammer, B. M. , Kramann R., Mallau M., Makowska A., van Roeyen C.R., Rong S., Buecher E.B.. Boor P., Kovacova K., Zok S., Denecke B., Stuettgen E., Otten S., Floege J., Kunter U. (2014): Mesenchymal stem cells from rats with chronic kidney disease exhibit premature senescence and loss of regenerative potential. PLoS One, 9 (3), e92-115, [3.057]
• Hanssen, L. , Alidoutsy, C., Djudjaj, S., Frye, B.C., Rauen, T., Boor, Pr., Mertens, P.R., van Roeyen, C.R., Tacke, F., Heymann, F., Tittel, A.P., Koch, A., Floege, J., Ostendorf, T., Raffetseder, U. (2013): YB-1 is an early and central mediator of bacterial and sterile inflammation in vivo.. The Journal of Immunology, 191(5), 2604-2613, [4.179]
• Villa, L. , Boor P, Konieczny A, Kunter U, van Roeyen CRC, Denecke B, Gan L, Neusser MA and Cohen CD for the ERCB-Consortium, Eitner F, Scholl T, Ostendorf T, Floege J (2013): Late angiotensin II receptor blockade in progressive rat mesangioproliferative glomerulonephritis: new insights into mechanisms. The Journal of Pathology, 229 (5), 672-84, [7.430]
• Seikrit, C. , Henkel C, van Roeyen CRC, Bokemeyer D, Eitner F, Martin IV, Boor P, Ruth Knüchel, Meyer HE, Müller-Newen G, Eriksson U, Floege J, Ostendorf T. (2013): Biological responses to PDGF-AA versus PDGF-CC in renal fibroblasts. Nephrol Dial Transplant, Apr;28(4), 889-900, [4.085]
• Tenten, T. , Menzel S, Kunter U, Sicking EM, van Roeyen CVR, Sanden SK, Kaldenbach M, Boor P, Fuss A, Uhlig S, Lanzmich R, Dijkman H, Grepl M, Wild K, Kriz W, Smeets B, Floege J, Moeller MJ. (2013): Albumin is recycled from the primary urine by tubular transcytosis.. Journal of the American Society of Nephrology, 24 (12), 1966-1980, [8.491]
• van Roeyen, C. R. , Zok, S., Pruessmeyer, J., Boor, P., Nagayama, Y., Fleckenstein, S., Cohen, C. D., Eitner, F., Grone, H. J., Ostendorf, T., Ludwig, A., Floege, J. (2013): Growth arrest-specific protein 1 is a novel endogenous inhibitor of glomerular cell activation and proliferation. Kidney International, 83 (2), 251-263, [7.683]
• Smeets, B. , Boor P, Dijkman H, Sharma SV, Jirak P, Khera S, Mooren F, Berger K, Bornemann J, Gelman IH, Floege J, van der Vlag J, Wetzels JFM, Moeller MJ. (2013): Proximal tubular cells contain a phenotypically distinct, scattered cell population involved in tubular regeneration. The Journal of Pathology, 229 (5), 645-59, [7.381]
• Martin, I. V. , Borkham-Kamphorst E, Zok S, van Roeyen CRC, Eriksson U, Boor P, Hiththetiya K, Fischer HP, Wasmuth HE, Weiskirchen R, Eitner F, Floege J, Ostendorf T. (2013): Platelet-Derived Growth Factor (PDGF)-C Neutralization Reveals Differential Roles of PDGF Receptors in Liver and Kidney Fibrosis. The American Journal of Pathology, 182 (1), 107-117, [4.206]
• Strüßmann, T. , Tillmann, S., Wirtz, T., Bucala, R., von Hundelshausen, P., Bernhagen, J. (2013): Platelets are a previously unrecognised source of MIF.. Thromb Haemost, 110(5), 1004-1013, [5.565]
• Bábíčková, J. , Tóthová Ľ, Boor P, Celec P. (2013): In vivo phage display – A discovery tool in molecular biomedicine.. Biotechnology Advances, 31 (8), 1247-1259, [11.800]
• Kaldenbach, M. , Giebeler, A., Tschaharganeh, D. F., Erschfeld, S., Wasmuth, H. E., Dolle, L., Floege, J., Trautwein, C., Streetz, K. L. (2012): Hepatocyte growth factor/c-Met signalling is important for the selection of transplanted hepatocytes. Gut, 61 (8), 1209-1218, [14.921]
• van Roeyen, C. R , Ostendorf, T., Floege, J. (2012): The platelet-derived growth factor system in renal disease: An emerging role of endogenous inhibitors. European Journal of Cell Biology, 91 (6-7), 542-551, [4.011]
• Sicking, E. M. , Fuss, A., Uhlig, S., Jirak, P., Dijkman, H., Wetzels, J., Engel, D. R., Urzynicok, T., Heidenreich, S., Kriz, W., Kurts, C., Ostendorf, T., Floege, J., Smeets, B., Moeller, M. J. (2012): Subtotal ablation of parietal epithelial cells induces crescent formation. Journal of the American Society of Nephrology, 23, 629-640, [8.491]
• Ostendorf, T. , Eitner, F., Floege, J. (2012): The PDGF family in renal fibrosis. Pediatr Nephrol, 27, 1041-1050, [2.338]
• Nelson, P. J. , Rees, A. J., Griffin, M. D., Hughes, J., Kurts, C., Duffield, J. (2012): The renal mononuclear phagocytic system. Journal of Americal Society of Nephrology, 23, 194-203, [8.491]
• Borkham-Kamphorst, E. , van Roeyen, C. R., Van de Leur, E., Floege, J., Weiskirchen, R. (2012): CCN3/NOV small interfering RNA enhances fibrogenic gene expression in primary hepatic stellate cells and cirrhotic fat storing cell line CFSC. Journal of Cell Communication and Signaling, 6, 11-25, [3.123]
• van Roeyen CRC, Boor P. , Borkham-Kamphorst E, Rong S, Kunter U, Martin IV, Kaitovic A, Fleckenstein S, Perbal B, Weiskirchen R, Ostendorf T, Floege J. (2012): A novel, dual role of CCN3 in experimental glomerulonephritis: pro-angiogenic and anti-mesangioproliferative effects. American Journal of Pathology, 180, 1979-1990, [4.206]
• Kabgani N. , Grigoleit T, Schulte K, Sechi A, Sauer-Lehnen S, Tag C, Boor P, Kuppe C, Warsow G, Schordan S, Mostertz J, Chilukoti R, Homuth G, Endlich N, Tacke F, Weiskirchen R, Fuellen G, Endlich K, Floege J, Smeets B, Moeller MJ. (2012): Primary cultures of glomerular parietal epithelial cells or podocytes with proven origin. PLoS ONE, 7, [3.057]
• Boor P. , Floege J. (2012): The renal (myo-)fibroblast: a heterogenous group of cells. Nephrol Dial Transplant, 27, 3027–3036, [4.085]
• Villa, L. , Boor, P., Konieczny, A., Kunter, U., van Roeyen, C. R., Denecke, B., Gan, L., Kupper, M. B., Hoffmann, K., Eitner, F., Ostendorf, T., Floege, J. (2011): Effects and mechanisms of angiotensin II receptor blockade with telmisartan in a normotensive model of mesangioproliferative nephritis.. Nephrology Dialysis Transplantation, 26 (10), 3131-3143, [4.085]
• Smeets, B. , Kuppe, C., Sicking, E. M., Fuss, A., Jirak, P., van Kuppevelt, T. H., Endlich, K., Wetzels, J. F., Grone, H. J., Floege, J., Moeller, M. J. (2011): Parietal epithelial cells participate in the formation of sclerotic lesions in focal segmental glomerulosclerosis. Journal of American Society of Nephrology, 11 (7), 1262-1274, [8.491]
• Rauen, T. , Weiskirchen, R., Floege, J. (2011): In search of early events in the development of chronic kidney disease: the emerging role for lipocalin-2/NGAL. Nephrology Dialysis Transplantation, 26, 445-447, [4.085]
• Kramann, R. , Couson, S. K., Neuss, S., Kunter, U., Bovi, M., Bornemann, J., Knuchel, R., Jahnen-Dechent, W., Floege, J., Schneider, R. K. (2011): Exposure to uremic serum induces a procalcific phenotype in human mesenchymal stem cells. Arterioscler Thromb Vasc Bio, 31 (9), e45-54, [5.969]
• Kunter, U. , Rong, S., Moeller, M. J., Floege, J. (2011): Mesenchymal stem cells as a therapeutic approach to glomerular diseases: benefits and risks. Kidney International Supplements, 1 (3), 68-73, [7.026]
• van Roeyen, C. R. , Eitner, F., Boor, P., Moeller, M. J., Raffetseder, U., Hanssen, L., Bucher, E., Villa, L., Banas, M. C., Hudkins, K. L., Alpers, C. E., Ostendorf, T., Floege, J. (2011): Induction of progressive glomerulonephritis by podocyte-specific overexpression of platelet-derived growth factor-D. Kidney International, 80 (12), 1292-1305, [7.683]
• Raffetseder, U. , Rauen, T., Boor, P., Ostendorf, T., Hanssen, L., Floege, J., En-Nia, A., Djudjaj, S., Frye, B. C., Mertens, P. R. (2011): Extracellular YB-1 blockade in experimental nephritis upregulates notch-3 receptor expression and signaling. Nephron Experimental Nephrology, 118, 100-108, [1.531]
• Pieper-Furst, U. , Hall, R., Huss, S., Hochrath, K., Fischer, H. P., Tacke, F., Weiskirchen, R., Lammert, F. (2011): Expression of the megalin C-terminal fragment by macrophages during liver fibrogenesis in mice. Biochimica et Biophysica Acta, 1812 (12), 1640-1648, [5.158]
• Boor, P. , Celec, P., Martin, I. V., Villa, L., Hodosy, J., Klenovicsova, K., Esposito, C., Schafer, S., Albrecht-Kupper, B., Ostendorf, T., Heidland, A., Sebekova, K. (2011): The peroxisome proliferator-activated receptor-alpha agonist, BAY PP1, attenuates renal fibrosis in rats.. Kidney International, 80, 1182-1197, [7.683]
• Hanssen, L. , Frye, B. C., Ostendorf, T., Alidousty, C., Djudjaj, S., Boor, P., Rauen, T., Floege, J., Mertens, P. R., Raffetseder, U. (2011): Y-box binding protein-1 mediates profibrotic effects of calcineurin inhibitors in the kidney. Journal of Immunology, 187 (1), 298-308, [4.179]
• Hausmann, R. , Kuppe, C., Egger, H., Schweda, F., Knecht, V., Elger, M., Menzel, S., Somers, D., Braun, G., Fuss, A., Uhlig, S., Kriz, W., Tanner, G., Floege, J., Moeller, M. J. (2010): Electrical forces determine glomerular permeability. Journal of American Society of Nephrology, 21 (12), 2053-2058, [8.491]
• Boor, P. , Ostendorf, T., Floege, J. (2010): Renal fibrosis: novel insights into mechanisms and therapeutic targets. Nature Reviews Nephrology, 6 (11), 643-565, [9.463]
• Boor, P. , van Roeyen, C. R., Kunter, U., Villa, L., Bucher, E., Hohenstein, B., Hugo, C. P., Eriksson, U., Satchell, S. C., Mathieson, P. W., Eitner, F., Floege, J., Ostendorf, T. (2010): PDGF-C mediates glomerular capillary repair. American Journal of Pathology, 177 (1), 58-69, [4.206]
• Smeets, B. , Uhlig, S., Fuss, A., Mooren, F., Wetzels, J. F., Floege, J., Moeller, M. J. (2009): Tracing the origin of glomerular extracapillary lesions from parietal epithelial cells.. J Am Soc Nephrol, 20, 2604-2615, [8.491]
• Heymann, F. , Meyer-Schwesinger, C., Hamilton-Williams, E. E., Hammerich, L., Panzer, U., Kaden, S., Quaggin, S. E., Floege, J., Grone, H. J., Kurts, C. (2009): Kidney dendritic cell activation is required for progression of renal disease in a mouse model of glomerular injury. J Clin Invest, 119, 1286-1297, [12.575]
• Appel, D. , Kershaw, D. B., Smeets, B., Yuan, G., Fuss, A., Frye, B., Elger, M., Kriz, W., Floege, J., Moeller, M. J. (2009): Recruitment of podocytes from glomerular parietal epithelial cells. J Am Soc Nephrol, 20, 333-343, [8.491]